| Over the past 40 year’s development,our economy has continued to grow rapidly and achieved great achievements.With the continuous increase of the government’s investment in medical and health services,the medical industry has achieved rapid development.XLT Pharmaceutical Co.,Ltd.is a comprehensive chemical drug and innovative drug company established in 1998.Its main business includes the production,sales and research and development of drugs,and it was successfully appearing on the market in 2009.XLT Pharmaceutical Co.,Ltd.has been selected as one of the "Top 10 Listed Pharmaceutical Companies with R&D Innovation in China" for two years,and has been selected as one of the"Top 20 Competitive Listed Pharmaceutical Companies in China" for many times.After the 18th National Congress of the Communist Party of China,our economic development has entered a new normal of steady growth,industrial restructuring and many policies to deepen the reform of the medical system have been implemented in a concentrated manner.The structural differentiation of the pharmaceutical industry has become more and more obvious.The emergence of pharmaceutical enterprises has entered a new era for the development of pharmaceutical enterprises,and enterprises have been upgraded and transformed and moved towards the road of implementing patent management.Since 2019,the profit and revenue scale of XLT Pharmaceutical Company has dropped significantly,formulating a scientific development strategy has become an important and urgent thing for the survival and development of XLT Pharmaceutical Company.Through the research on XLT Pharmaceutical Company,this article flexibly uses strategic tools such as PEST analysis model,Porter’s five forces model,internal and external factor evaluation matrix,SWOT analysis model and quantitative strategic planning matrix to identify and quantify the external Opportunities and internal Advantages,the external Threats and internal Disadvantages owned by XLT Pharmaceutical Company.The differentiation strategy should be implemented,through the strategic implementation content of marketing planning,brand building planning and product research and development planning,and build an excellent corporate culture,establish an efficient incentive mechanism,bring in high-quality talents and create of a learning organization as safeguards,making a medium-and long-term strategy implementation roadmap for XLT Pharmaceuticals.This research is dedicated to providing XLT pharmaceutical company with an operational,systematic and theoretically development strategy and implementation path to help them cope with complex internal and external environments.At the same time,hope this research can provide relevant reference for small and medium-sized pharmaceutical companies to formulate and implement business development strategies,help them adapt to the more complex and changeable competitive environment in the future. |